Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spainq
Material type:
TextSubject(s): Online resources:
| Item type | Current library | Call number | URL | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
eBooks
|
Link to resource | Available |
eBooks
There are no comments on this title.